Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Bausch Health Companies Inc |
4/11 | 8,340 USD
+2,46% |
+2,46% |
|
Baxter |
4/11 | 26,500 USD
+3,96% |
+3,96% |
Bayer AG |
4/11 | 54,240 EUR
+4,63% |
+4,63% |
|
Beam Therapeutics Inc |
4/11 | 27,790 USD
+5,55% |
+5,55% |
|
Becton, Dickinson And Co. |
4/11 | 209,190 USD
+5,56% |
+5,56% |
|
BeiGene Ltd |
4/11 | 377,780 USD
+6,42% |
+6,42% |
|
Bellring Brands Inc |
4/11 | 10,220 USD
+8,49% |
+8,49% |
|
Benitec Biopharma Inc |
4/11 | 9,280 USD
+10,48% |
+10,48% |
Beximco Pharmaceuticals Limited - GDR - Reg S |
20/10 | 52,500 GBX
+1,94% |
+1,94% |
|
BeyondSpring Inc |
4/11 | 0,679 USD
+9,34% |
+9,34% |
|
Bicycle Therapeutics Plc |
4/11 | 3,720 USD
+1,36% |
+1,36% |
|
Bio-Path Holdings Inc |
4/11 | 0,000 USD
-40,00% |
-40,00% |
|
Bio-Rad Laboratories Inc. |
4/11 | 379,500 USD
0,00% |
0,00% |
|
Bio-Rad Laboratories Inc. |
4/11 | 379,990 USD
+1,35% |
+1,35% |
|
Bio-Techne Corp |
4/11 | 72,730 USD
+0,10% |
+0,10% |
|
BioCardia Inc. |
4/11 | 0,913 USD
-0,92% |
-0,92% |
|
Biocryst Pharmaceuticals Inc. |
4/11 | 8,240 USD
-3,85% |
-3,85% |
|
Biogen |
4/11 | 254,460 USD
+2,22% |
+2,22% |
|
Biohaven Ltd |
4/11 | 15,240 USD
-2,37% |
-2,37% |
|
Biolife Solutions Inc |
5/10 | 38,610 USD
+3,51% |
+3,51% |
|
Bioline Rx Ltd |
4/11 | 1,860 USD
-2,62% |
-2,62% |
|
Biomarin Pharmaceutical Inc. |
4/11 | 57,130 USD
+2,64% |
+2,64% |
|
Biomerica Inc. |
4/11 | 1,735 USD
+2,06% |
+2,06% |
Biomerieux |
4/11 | 97,650 EUR
+3,06% |
+3,06% |
|
BiomX Inc |
8/10 | 0,292 USD
-5,72% |
-5,72% |
|
Bionano Genomics Inc |
4/11 | 1,190 USD
-0,83% |
-0,83% |
|
BioNTech SE |
4/11 | 90,700 USD
+4,35% |
+4,35% |
|
Biophytis |
4/11 | 0,040 EUR
+54,26% |
+54,26% |
|
BioRestorative Therapies Inc |
4/11 | 1,510 USD
+2,03% |
+2,03% |
BioSenic |
26/05 | 0,002 EUR
-9,09% |
-9,09% |
Biosyent Inc |
4/11 | 17,150 CAD
+1,78% |
+1,78% |
|
Biosynex |
4/11 | 0,820 EUR
-3,07% |
-3,07% |
|
BioVie Inc |
4/11 | 1,340 USD
-22,54% |
-22,54% |
|
BioXcel Therapeutics Inc |
8/10 | 0,048 USD
-3,33% |
-3,33% |
|
Black Diamond Therapeutics Inc |
3/11 | 1,810 USD
+3,43% |
+3,43% |
|
Bluelinea SA |
4/11 | 0,057 EUR
+2,73% |
+2,73% |
|
Boiron |
4/11 | 19,050 EUR
+1,33% |
+1,33% |
|
Bone Biologics Corp |
4/11 | 0,347 USD
-1,81% |
-1,81% |
|
Boston Scientific Corp. |
4/11 | 45,820 USD
+5,33% |
+5,33% |
|
Boundless Bio Inc. |
4/11 | 2,400 USD
+0,84% |
+0,84% |
|
BRAIN Biotech AG |
4/11 | 2,640 EUR
-1,49% |
-1,49% |
|
Brainstorm Cell Therapeutics, Inc. |
4/11 | 0,826 USD
-2,81% |
-2,81% |
|
Brainsway Ltd |
4/11 | 11,210 USD
+0,54% |
+0,54% |
|
BriaCell Therapeutics Corp |
4/11 | 3,190 USD
+5,98% |
+5,98% |
|
BridgeBio Pharma Inc |
4/11 | 77,890 USD
+5,21% |
+5,21% |
|
Bristol-Myers Squibb Co. |
4/11 | 64,190 USD
+4,02% |
+4,02% |
|
Bruker Corp |
4/11 | 63,790 USD
+12,90% |
+12,90% |